Follow the American Society of Hematology ASH conversations! - http://pharmastrategyblog.com/2011...
Dec 10, 2011
from
Sally Church
Interested in Pharma, Biotech, Science and cancer... Find me at http://www.pharmastrategyblog.com also love food, wine, the NFL and cricket. Hi!
What’s hot at the American Society of Hematology 2011? - http://pharmastrategyblog.com/2011...
Dec 10, 2011
from
What’s hot at SABCS – Update 1 - http://pharmastrategyblog.com/2011...
Dec 8, 2011
from
Video preview of San Antonio Breast Cancer Symposium 2011 - http://pharmastrategyblog.com/2011...
Dec 7, 2011
from
Follow the conversation from 2011 San Antonio Breast Cancer Symposium - http://pharmastrategyblog.com/2011...
Dec 6, 2011
from
EGFR activates mTORC2 in glioblastoma – a potential role for new therapies - http://pharmastrategyblog.com/2011...
Dec 1, 2011
from
Gone to dog drug heaven… - http://pharmastrategyblog.com/2011...
Nov 29, 2011
from
Exciting new approach to targeted therapy in prostate cancer - http://pharmastrategyblog.com/2011...
Nov 28, 2011
from
Update from AACR Molecular Targets 2011 #2 – Angiogenesis - http://pharmastrategyblog.com/2011...
Nov 22, 2011
from
Update from AACR Molecular Targets 2011 #1 – Breast Cancer - http://pharmastrategyblog.com/2011...
Nov 21, 2011
from
AACR Molecular Targets Meeting - http://pharmastrategyblog.com/2011...
Nov 12, 2011
from
Epigenetics – an emerging new potential treatment for lung cancer? - http://pharmastrategyblog.com/2011...
Nov 11, 2011
from
Update on pancreatic Neuroendocrine Tumours (NET) - http://pharmastrategyblog.com/2011...
Nov 10, 2011
from
Redefining subsets of triple negative breast cancer - http://pharmastrategyblog.com/2011...
Nov 9, 2011
from
How a metabolic protein PKM2 may have a key role in tumorigenesis - http://pharmastrategyblog.com/2011...
Nov 8, 2011
from
Excellent news in Advanced Prostate Cancer – Medivation’s MDV3100 meets primary endpoint - http://pharmastrategyblog.com/2011...
Nov 3, 2011
from
Understanding cancer metastasis – possible new therapeutic targets - http://pharmastrategyblog.com/2011...
Nov 1, 2011
from
A year in the life of Pharma Strategy Blog - http://pharmastrategyblog.com/2011...
Oct 31, 2011
from
Beautiful - http://pharmastrategyblog.com/2011...
Oct 31, 2011
from
Update on EGFR resistance in lung cancer: new directions - http://pharmastrategyblog.com/2011...
Oct 25, 2011
from
Update on cabozantinib in medullary thyroid cancer - http://pharmastrategyblog.com/2011...
Oct 24, 2011
from
Useful resource on new therapies for lung cancer - http://pharmastrategyblog.com/2011...
Oct 21, 2011
from
The elusive mystery of KRAS and EGFR inhibitors in colorectal cancer - http://pharmastrategyblog.com/2011...
Oct 20, 2011
from
Update on ADCs and immunotoxins in hematologic malignancies - http://pharmastrategyblog.com/2011...
Oct 18, 2011
from
Pharma Strategy Blog feed is back up - http://pharmastrategyblog.com/2011...
Oct 17, 2011
from
When is NICE is not so nice? - http://pharmastrategyblog.com/2011...
Oct 14, 2011
from
Ovarian cancer patients with BRCA2 mutated tumors live longer - http://pharmastrategyblog.com/2011...
Oct 12, 2011
from
Upcoming Fall cancer meetings - http://pharmastrategyblog.com/2011...
Oct 11, 2011
from
On Science, Blogging and Drug Development - http://pharmastrategyblog.com/2011...
Oct 10, 2011
from
Bevacizumab Has Differential and Dose-Dependent Effects on Glioma Blood Vessels and Tumor Cells - http://clincancerres.aacrjournals.org/content...
Oct 8, 2011
from
VEGF, VEGF-A
- Sally Church
Austin is really overcast with dark clouds. Maybe I brought the rain after all @thecancergeek @jodyms - http://www.flickr.com/photos...
Oct 7, 2011
from
@thecancergeek Guess where I am - Ritas and Chile Rellenos, yum! - http://www.flickr.com/photos...
Oct 6, 2011
from